Intraperitoneal cisplatin and paclitaxel in ovarian cancer Academic Article uri icon

Overview

MeSH Major

  • Adenocarcinoma
  • Antineoplastic Combined Chemotherapy Protocols
  • Cisplatin
  • Ovarian Neoplasms
  • Paclitaxel

abstract

  • As compared with intravenous paclitaxel plus cisplatin, intravenous paclitaxel plus intraperitoneal cisplatin and paclitaxel improves survival in patients with optimally debulked stage III ovarian cancer.

publication date

  • May 2006

Research

keywords

  • Academic Article

Identity

Language

  • eng

Digital Object Identifier (DOI)

  • 10.1056/NEJMoa052985

PubMed ID

  • 16394300

Additional Document Info

start page

  • 34

end page

  • 43

volume

  • 354

number

  • 1